122 related articles for article (PubMed ID: 23484374)
1. [Clinical experience of primaquine use for treatment of vivax and ovale malaria in Japanese travelers].
Kobayashi T; Kato Y; Yamauchi Y; Ujiie M; Takeshita N; Mizuno Y; Kanagawa S; Kano S; Ohmagari N
Kansenshogaku Zasshi; 2013 Jan; 87(1):22-6. PubMed ID: 23484374
[TBL] [Abstract][Full Text] [Related]
2. Optimal primaquine use for radical cure of Plasmodium vivax and Plasmodium ovale malaria in Japanese travelers--A retrospective analysis.
Shimizu S; Kikuchi T; Koga M; Kato Y; Matsuoka H; Maruyama H; Kimura M;
Travel Med Infect Dis; 2015; 13(3):235-40. PubMed ID: 25482427
[TBL] [Abstract][Full Text] [Related]
3. Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax.
Milligan R; Daher A; Villanueva G; Bergman H; Graves PM
Cochrane Database Syst Rev; 2020 Aug; 8():CD012656. PubMed ID: 32816320
[TBL] [Abstract][Full Text] [Related]
4. Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
Watson J; Taylor WRJ; Bancone G; Chu CS; Jittamala P; White NJ
PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006440. PubMed ID: 29677199
[TBL] [Abstract][Full Text] [Related]
5. Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine.
Galappaththy GN; Tharyan P; Kirubakaran R
Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD004389. PubMed ID: 24163057
[TBL] [Abstract][Full Text] [Related]
6. The clinical and public health problem of relapse despite primaquine therapy: case review of repeated relapses of Plasmodium vivax acquired in Papua New Guinea.
Ingram RJ; Crenna-Darusallam C; Soebianto S; Noviyanti R; Baird JK
Malar J; 2014 Dec; 13():488. PubMed ID: 25495607
[TBL] [Abstract][Full Text] [Related]
7. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
Rodrigo C; Rajapakse S; Fernando D
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD010458. PubMed ID: 32892362
[TBL] [Abstract][Full Text] [Related]
8. Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.
Baird JK; Battle KE; Howes RE
Malar J; 2018 Jan; 17(1):42. PubMed ID: 29357870
[TBL] [Abstract][Full Text] [Related]
9. Primaquine treatment for Plasmodium vivax--an essential tool for malaria control and elimination in Papua New Guinea.
Betuela I; Robinson LJ; Hetzel MW; Laman M; Siba PM; Bassat Q; Mueller I
P N G Med J; 2014; 57(1-4):68-74. PubMed ID: 26930890
[TBL] [Abstract][Full Text] [Related]
10. Compliance to recommendations for the management of curative treatment of Plasmodium vivax/ovale infections.
Faucher JF; Bellanger AP; Shaniya N; Hustache-Mathieu L; Hoen B; Chirouze C
Med Mal Infect; 2014 Aug; 44(8):387-9. PubMed ID: 25015307
[TBL] [Abstract][Full Text] [Related]
11. [Role of primaquine in malaria control and elimination in French-speaking Africa].
Briolant S; Pradines B; Basco LK
Bull Soc Pathol Exot; 2017 Aug; 110(3):198-206. PubMed ID: 28417346
[TBL] [Abstract][Full Text] [Related]
12. Relapse of Plasmodium vivax and Plasmodium ovale Malaria With and Without Primaquine Treatment in a Nonendemic Area.
Wångdahl A; Sondén K; Wyss K; Stenström C; Björklund D; Zhang J; Hervius Askling H; Carlander C; Hellgren U; Färnert A
Clin Infect Dis; 2022 Apr; 74(7):1199-1207. PubMed ID: 34216464
[TBL] [Abstract][Full Text] [Related]
13. [A study of relapsed cases of vivax malaria after the standard primaquine therapy].
Kimura M; Tomizawa I; Takizawa Y; Ohtomo H
Kansenshogaku Zasshi; 1996 Oct; 70(10):1086-91. PubMed ID: 8952270
[TBL] [Abstract][Full Text] [Related]
14. Implementation of G6PD testing and primaquine for
Kitchakarn S; Lek D; Thol S; Hok C; Saejeng A; Huy R; Chinanonwait N; Thimasarn K; Wongsrichanalai C
WHO South East Asia J Public Health; 2017 Sep; 6(2):60-68. PubMed ID: 28857064
[TBL] [Abstract][Full Text] [Related]
15. Primaquine: the risks and the benefits.
Ashley EA; Recht J; White NJ
Malar J; 2014 Nov; 13():418. PubMed ID: 25363455
[TBL] [Abstract][Full Text] [Related]
16. [Two imported and relapsed of Plasmodium vivax malaria cases and primaquine prophylaxis].
Hatipoğlu M; Ulçay A; Turhan V; Karagöz E; Erdem H; Acar A; Oncül O; Görenek L
Turkiye Parazitol Derg; 2014 Jun; 38(2):120-3. PubMed ID: 25016120
[TBL] [Abstract][Full Text] [Related]
17. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
Rajapakse S; Rodrigo C; Fernando SD
Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD010458. PubMed ID: 25921416
[TBL] [Abstract][Full Text] [Related]
18. Multiple relapses of Plasmodium vivax malaria acquired from West Africa and association with poor metabolizer CYP2D6 variant: a case report.
He X; Pan M; Zeng W; Zou C; Pi L; Qin Y; Zhao L; Qin P; Lu Y; Baird JK; Huang Y; Cui L; Yang Z
BMC Infect Dis; 2019 Aug; 19(1):704. PubMed ID: 31399061
[TBL] [Abstract][Full Text] [Related]
19. Association of Impaired Cytochrome P450 2D6 Activity Genotype and Phenotype With Therapeutic Efficacy of Primaquine Treatment for Latent Plasmodium vivax Malaria.
Baird JK; Louisa M; Noviyanti R; Ekawati L; Elyazar I; Subekti D; Chand K; Gayatri A; Instiaty ; Soebianto S; Crenna-Darusallam C; Djoko D; Hasto BD; Meriyenes D; Wesche D; Nelwan EJ; Sutanto I; Sudoyo H; Setiabudy R
JAMA Netw Open; 2018 Aug; 1(4):e181449. PubMed ID: 30646129
[TBL] [Abstract][Full Text] [Related]
20. G6PD testing and radical cure for Plasmodium vivax in Cambodia: A mixed methods implementation study.
Kheang ST; Ridley R; Ngeth E; Ir P; Ngor P; Sovannaroth S; Lek D; Phon S; Kak N; Yeung S
PLoS One; 2022; 17(10):e0275822. PubMed ID: 36264996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
